(NCI) Therapeutics (e.g. Small Molecules, Biologics, Radiomodulators, and Cell-based Therapies) In Vitro and In Vivo Diagnostics (e.g. Companion Diagnostics and Prognostic Technologies) Imaging Technologies (e.g. Agents, Devices, and Image-Guided Interventions) Devices for Cancer Therapy (e.g. Interventional Devices, Surgical, Radiation and Ablative Therapies) Agents for Cancer Prevention (e.g., Vaccines, but not for Cancer Prevention”) “Technologies Development of Low Cost Technologies for Global Health Development of Digital Health (NCATS) Innovative platforms for identification and prioritization of targets for therapeutic intervention with clear clinical impact. Technologies to determine alternative uses for existing therapeutic interventions.
(NCI) Therapeutics (e.g. Small Molecules, Biologics, Radiomodulators, and Cell-based Therapies) In Vitro and In Vivo Diagnostics (e.g. Companion Diagnostics and Prognostic Technologies) Imaging Technologies (e.g. Agents, Devices, and Image-Guided Interventions) Devices for Cancer Therapy (e.g. Interventional Devices, Surgical, Radiation and Ablative Therapies) Agents for Cancer Prevention (e.g., Vaccines, but not “Technologies for Cancer Prevention”) Development of Low Cost Technologies for Global Health Development of Digital Health (NCATS) Innovative platforms for identification and prioritization of targets for therapeutic intervention with clear clinical impact. Technologies to determine alternative uses for existing therapeutic interventions.
NIH_Topics_for_Budget_Waivers.docx